LOS ANGELES, CA, Jun 11, 2012 (MARKETWIRE via COMTEX) -- MMRGlobal, Inc. ("MMR") today announced that it has agreements in place to launch the Company's health IT products and services in Europe. MMR plans on installing its MMRPro document management and imaging system in St. Helens Hospital in the United Kingdom ( http://www.sthk.nhs.uk ). As a result of the Company's existing relationships and agreements with Kodak distributors, Chartis and others, MMR is expanding in the UK and France, which will also include its MyMedicalRecords Personal health Record (PHR).
According to Richard M. Lagani, MMRGlobal Executive Vice President, "In response to a global initiative to adopt Electronic Medical Record systems and Personal Health Records, I have made numerous presentations in Europe over the past several years and now will begin the process of offering MMRPro and MyMedicalRecords PHR services across the UK and in other countries in Europe."
In addition, following MMRGlobal's Annual Meeting of Stockholders on June 20, 2012, the Company will host a management meeting in Los Angeles with Luo Jianhui, Vice-President and Chairman of Unisoft Group, Unis-Tonghe Technology (Zhengzhou) Co., Ltd., regarding the Joint Venture agreement between Unis and MMR, which has recently received several governmental approvals in China. Luo Jianhui will also be accompanied by executives from Alcatel-Lucent in China who are working with MMR and Unis to launch the Unis Tonghe MMR International Health Management Service Co., Ltd. Electronic Medical Record systems business.
In Australia, MMR is working with its licensee VisiInc PLC to market Personal Health Records to government, healthcare professionals and consumers. The Visi PHR will incorporate Personal Health Record patents issued in Australia and owned by MMR. There continues to be significant movement regarding the adoption of PHRs in Australia. Starting July 1, 2012, patients will be able to opt-in and register to have an eHealth record where they can create their health summary, such as listing their medications and allergies. The entire process is projected to take as long as 10 years, which underscores the value of MMR's patents and the VisiInc relationship.
About MMRGlobal, Inc.
MMRGlobal, Inc., through its wholly-owned operating subsidiary, MyMedicalRecords, Inc., provides secure and easy-to-use online Personal Health Records ("PHRs") and electronic safe deposit box storage solutions, serving consumers, healthcare professionals, employers, insurance companies, financial institutions, and professional organizations and affinity groups. The MyMedicalRecords PHR enables individuals and families to access their medical records and other important documents, such as birth certificates, passports, insurance policies and wills, anytime from anywhere using the Internet. MyMedicalRecords is built on proprietary, patented technologies to allow documents, images and voicemail messages to be transmitted and stored in the system using a variety of methods, including fax, phone, or file upload without relying on any specific electronic medical record platform to populate a user's account. The Company's professional offering, MMRPro, is designed to give physicians' offices an easy and cost-effective solution to digitizing paper-based medical records and sharing them with patients in real time through an integrated patient portal. MMR is an Independent Software Vendor Partner with Kodak to deliver an integrated turnkey EMR solution for healthcare professionals. Through its merger with Favrille, Inc. in January 2009, the Company acquired intellectual property biotech assets that include anti-CD20 antibodies and data and samples from its FavId(TM)/Specifid(TM) vaccine clinical trials for the treatment of B-Cell Non-Hodgkin's lymphoma. To learn more about MMRGlobal, Inc. visit http://www.mmrglobal.com . View demos and video tutorials of the Company's products and services at http://www.mmrtheater.com .
Forward-Looking Statements
All statements in this press release that are not strictly historical in nature, including future performance, management's expectations, beliefs, intentions, estimates or projections, constitute "forward-looking statements." Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the Company's actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements. Some can be identified by the use of words (and their derivations) such as "need," "possibility," "intend," "offer," "development," "if," "negotiate," "when," "begun," "believe," "achieve," "will," "estimate," "expect," "maintain," "plan," and "continue," or the negative of these words. Actual results and the timing of selected events may differ materially from the results predicted, and reported results should not be considered as an indication of future performance. Factors that could cause or contribute to such differences include, but are not limited to, the risk the Company's products are not adopted or viewed favorably by the healthcare community and consumer retail market; business prospects, results of operations or financial condition; success of new distribution channels and personal health records adoption; uncertainties associated with doing business internationally across borders and territories; timing and volume of sales and installations; length of sales cycles and the installation process; market acceptance of new product introductions; ability to establish and maintain strategic relationships; relationships with licensees; competitive product offerings and promotions; changes in government laws and regulations and future changes in tax legislation and initiatives in the healthcare industry; undetected errors in our products; possibility of interruption at our data centers; risks related to third party vendors; risks related to obtaining and integrating third-party licensed technology; risks related to a security breach by third parties; maintaining, developing and defending our intellectual property rights; marketing and exploitation of our patent portfolio both in the U.S. and internationally; and additional risks discussed in the Company's filings with the Securities and Exchange Commission. The Company is providing this information as of the date of this release and, except as required by law, does not undertake any obligation to update any forward-looking statements contained in this release as a result of new information, future events or otherwise
Original Post